Trump Launches Drug Pricing Initiatives as Pharmaceutical M&A Activity Continues
President Trump has introduced new pharmaceutical pricing programs, including TrumpRx discount coupons, while industry consolidation proceeds with major acquisitions.
President Trump has introduced new pharmaceutical pricing programs, including TrumpRx discount coupons, while industry consolidation proceeds with major acquisitions.

The nation's largest health insurer will remove approval requirements for select treatments and procedures.

Multiple states are reducing Medicaid coverage for weight-loss drugs while federal health programs undergo policy modifications.

New medical research explores connections between sleep patterns and dementia risk, while other studies examine gut bacteria's role in sepsis susceptibility.
Brazilian health authorities are investigating a suspected Ebola case in São Paulo amid ongoing global health surveillance efforts.

A suspect in the death of a five-year-old Aboriginal girl was transferred from Alice Springs to Darwin following his arrest and subsequent community unrest.

New research suggests no amount of alcohol consumption is safe, contradicting previous beliefs about health benefits of moderate drinking.

Vermont enacted the nation's first state-level ban on paraquat, a weedkilling pesticide linked to increased Parkinson's disease risk.

Health officials activate six-day heat alert for parts of England as exceptional temperatures forecast for May bank holiday period.

The Trump administration said baby formula samples met safety standards, but health advocates cite data showing contamination.

Military personnel parachuted onto Tristan da Cunha to treat a British citizen with suspected hantavirus infection on the remote Atlantic island.

Recent developments in genetic testing for Huntington's disease and immune system treatments for lupus show promising results for patients with these conditions.

A2 Milk Company has recalled thousands of tins of imported infant formula in the United States after detection of a potentially harmful toxin.
The FDA approved Regeneron's Otarmeni, the first gene therapy for genetic hearing loss, as the company agreed to a drug pricing deal with the Trump administration.

New report finds Americans spend 18% of economy on healthcare, nearly twice peer nations' average, while achieving worse health outcomes than most developed countries.
Page 8 of 42 (620 stories)